BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
10 results:

  • 1. Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Ferro M; Chiujdea S; Vartolomei MD; Bove P; Porreca A; Busetto GM; Del Giudice F; Antonelli A; Foschi N; Racioppi M; Autorino R; Chiancone F; Longo N; Barone B; Crocetto F; Musi G; Luzzago S; Piccinelli ML; Mistretta FA; de Cobelli O; Tataru OS; Hurle R; Liguori G; Borghesi M; Veccia A; Greco F; Schips L; Marchioni M; Lucarelli G; Dutto D; Colucci F; Russo GI; Giudice AL; Montanari E; Boeri L; Simone G; Rosazza M; Livoti S; Gontero P; Soria F
    Clin Genitourin Cancer; 2024 Apr; 22(2):27-37. PubMed ID: 37661507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma.
    Lei M; Miao J
    BMC Urol; 2023 Jul; 23(1):118. PubMed ID: 37443069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: A multi-institutional study.
    Xu P; Zhang S; Cheng J; Cao B; Huang J; Li Y; Lin W; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Cheng J; Wang H
    Eur J Radiol; 2023 Feb; 159():110665. PubMed ID: 36566705
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predicting the probability of malignant pathological type of kidney cancer based on mass size: A retrospective study.
    Li J; Li X; Jiang Z; Hu C; Liu J; Huo J; Liu B
    Prog Urol; 2022 Oct; 32(12):849-855. PubMed ID: 36068150
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
    Di Nunno V; Mollica V; Brunelli M; Gatto L; Schiavina R; Fiorentino M; Santoni M; Montironi R; Caliò A; Eccher A; Milella M; Martignoni G; Brunocilla E; Massari F
    Mol Diagn Ther; 2019 Oct; 23(5):569-577. PubMed ID: 31332726
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prior History and Incidence of Cancer Impacts on Cardiac prognosis in Hospitalized Patients With Heart Failure.
    Yoshihisa A; Ichijo Y; Watanabe K; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Circ J; 2019 Jul; 83(8):1709-1717. PubMed ID: 31243245
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Renal cell carcinoma as first and second primary cancer: etiological clues from the Swedish Family-Cancer Database.
    Liu H; Hemminki K; Sundquist J
    J Urol; 2011 Jun; 185(6):2045-9. PubMed ID: 21496838
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.